Not actual patients.
Designed to fit
your lifestyle
Why HYMPAVZI?
Learn what sets HYMPAVZI apart.
Prefilled, fixed-dose† pen
The same dose comes in every pen, so there's no need to mix or measure.
Innovative
HYMPAVZI works to help achieve hemostasis (how your body stops or prevents bleeding) through rebalancing the clotting process.
Subcutaneous delivery
HYMPAVZI is injected under the skin, not into a vein.
No mandatory treatment-related lab monitoring
Talk to your doctor about lab monitoring that may be necessary for your condition.
- In the phase 3 BASIS Study, the primary objective was to measure the annualized bleed rate (ABR) of treated bleeds with HYMPAVZI prophylaxis vs on-demand factor-based treatment and vs factor-based prophylaxis after 12 months. 92% reduction in treated bleeds on HYMPAVZI compared with on-demand factor-based treatment (3.20 ABR vs 39.86 ABR). 36% reduction in treated bleeds on HYMPAVZI compared with routine prophylaxis treatment (5.09 ABR vs 7.90 ABR). Individual results may vary.
- Your first dose (loading dose) of HYMPAVZI is 300 mg (two 150 mg injections). Then you will inject a weekly (maintenance) dose as prescribed by your healthcare provider.
Download the patient brochure to find out how HYMPAVZI fits your lifestyle.
Learn how HYMPAVZI works